Phone: +1 (214) 912-7664
Email: info@bio-exec.com
Follow us:
Supporting Ophthalmic Innovation at Scale

Strategic Advisory & Execution for Ophthalmic Life Sciences

BioExec accelerates growth for ophthalmic and life science companies through a disciplined blend of strategic advisory, expert engagement, and hands-on execution—supporting innovation from early concept through market impact.

25+

years in biotech, pharma & medtech

50+

KOLs, advisors & expert relationships engaged

100+

programs, engagements & initiatives supported
Srini Kondapalli, MD
CEO & Founder, Rinsada
Commercial Strategy & KOL Engagement

BioExec provided strategic advisory and execution support across commercial planning and KOL engagement, helping align leadership priorities with market realities and expert insight.

Our
Commitment

BioExec is built to support organizations operating in complex, regulated,
and high-stakes environments. We partner closely with leadership teams
to bring clarity to strategy, rigor to execution, and credibility to every
engagement.

Our work is grounded in deep ophthalmic expertise, strong industry
relationships, and an unwavering focus on outcomes that matter—to
clinicians, patients, and stakeholders alike.

Our Services

What We Offer

Integrated strategic and execution support tailored to the unique needs of ophthalmic life sciences companies.

Commercial Strategy & Marketing

Go-to-market strategy, brand positioning, and launch planning informed by real-world market dynamics.

KOL & Market
Insights

KOL mapping, profiling, engagement planning, and insight generation to support strategic decision-making.

Operations and
Logistics

Advisory boards, scientific engagement, and medical education programs built with rigor and compliance in mind.

Growth and Market Acceleration

Live, virtual, and hybrid educational programs designed to inform, engage, and elevate clinical practice.

Sales & Market Access Enablement

Tools, messaging, and programs that support field teams and market access strategies.

Strategic Consulting & Interim
Resourcing

Fractional leadership and embedded support across commercial, medical, and operational functions.

Professional & Peer Education

End-to-end program management, coordination, and execution across regions and stakeholders.

Scientific & Medical Affairs

Scalable programs designed to support expansion, adoption, and sustained momentum.
Why Choose BioExec

A Partner Built for Complexity

1

2

3

4

Leadership-Driven

Led by senior operators with decades of experience across biotech, pharma, and medical devices.

Deep Ophthalmic Focus

Specialized expertise across ophthalmology, optometry, and niche pharma markets.

Integrated Model

A delivery model combining fractional leadership, expert networks, and scalable execution.

Global Reach, Local Execution

Programs executed across multiple regions with on-the-ground precision and cultural awareness.
Our Leadership

Meet the BioExec Team

Joe Boyd

President & COO

Jennifer Pikor

Chief Marketing Officer

Cha Lastimosa

Chief of Staff

Haranath Gnana

Technology Officer

Partner With BioExec Today

When the stakes are high and precision matters, BioExec brings the strategic clarity, industry experience, and
disciplined execution needed to move your program forward.

Frequently Asked Questions

How does BioExec ensure programs remain compliant and credible?

All engagements are designed with regulatory awareness and scientific integrity in mind. Our leadership team brings deep experience in medical affairs, commercial strategy, and compliant stakeholder engagement.

How are BioExec engagements typically structured?

Engagements are modular and customized based on scope — ranging from targeted advisory support to embedded fractional leadership across commercial and medical functions.

Does BioExec specialize only in ophthalmology?

Yes. BioExec focuses on ophthalmology, optometry, and adjacent life sciences markets to provide specialized, market-relevant expertise.

What does success look like in a BioExec engagement?

Success is measured by strategic clarity, disciplined execution, stakeholder alignment, and measurable progress toward defined commercial and clinical objectives.